Single sample, random access molecular diagnostics system
VERIS MDx System
Beckman Coulter has obtained the CE Mark on the VERIS MDx System for the quantitative and qualitative analysis of molecular targets from clinical patient specimens. The system integrates sample introduction, nucleic acid extraction, reaction setup, real-time PCR amplification/detection and results interpretation. As part of an initial focus on infectious diseases, the VERIS CMV assay has also obtained the CE Mark. This Polymerase Chain Reaction (PCR) assay is designed for the quantitative determination of CMV deoxyribonucleic acid (DNA) from human plasma. When used in conjunction with clinical presentation and other laboratory findings, the VERIS CMV assay aids in monitoring viral load.